Reports
Sale
Global Pharmaceutical Grade Lactose Market Size, Share: By Type: Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray-dried Lactose, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; 2024-2032
Global Pharmaceutical Grade Lactose Market Outlook
The global Pharmaceutical Grade Lactose market size was approximately USD 1.92 billion in 2023. The market is projected to grow at a CAGR of 7.2% between 2024 and 2032, reaching a value of around USD 3.63 billion by 2032.
Key Trends in the Market
Lactose, a sugar present in milk, comprises glucose and galactose. The enzyme, lactase, aids its breakdown in the small intestine. Insufficient lactase leads to undigested lactose, causing symptoms like bloating and diarrhoea.
In the pharmaceutical industry, lactose is a common excipient, present in over 20% of prescription medicines and 6% of over-the-counter drugs. Its functions as a flow agent, binder, and disintegrant make it valuable in various formulations like tablets, capsules, and oral solutions, enhancing pharmaceutical product quality and safety.
- Rising global investments in the healthcare sector are expected to strengthen the global pharmaceutical grade lactose market growth in the coming years. In the pharmaceutical industry, lactose is widely used as a filler to provide bulk for instance tablets, offer flow to a formulation, and as a binder to keep formulas together.
- The healthcare sector witnesses numerous companies vying for market share, delivering products to diverse end-users on a global scale. The increasing attempts by companies to gain a competitive edge through strategic product launches, expansions, and dedicated research and development initiatives are aiding the pharmaceutical grade lactose market demand globally.
- Increasing awareness of the benefits associated with pharmaceutical-grade lactose products and the rising recognition of the significance of infant nutrition are pivotal factors propelling market growth.
Pharmaceutical Grade Lactose Market Segmentation
Based on type, the market is categorised into crystalline monohydrate lactose, inhalation lactose, granulated lactose, and spray-dried lactose, among others. The major regional markets for Pharmaceutical Grade Lactose are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter’s five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global pharmaceutical grade lactose market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
- DFE Pharma GmbH & Co KG
- Fengchen Group Co.,Ltd
- Lactalis International
- ALPAVIT
- Kavya Pharma
- MEGGLE GmbH & Co. KG
- Surfachem Group Ltd.
- Others
Market Share by Type
As per the pharmaceutical grade lactose market analysis, crystalline monohydrate lactose secured a notable revenue share in the historical period. This can be attributed to its high purity, solubility, and flow properties, making it a preferred choice for manufacturers focused on ensuring the safety and efficacy of their pharmaceutical products.
Specifically formulated for dry powder inhalers (DPIs), inhalation lactose serves as a carrier for active pharmaceutical ingredients (APIs). Manufactured through a comprehensive process involving spray drying and sieving, the lactose particles in DPIs typically range from 15 to 90 microns, facilitating efficient delivery of inhaler medicine to the lungs.
In the pharmaceutical industry, spray-dried lactose is employed as a filler or carrier, produced by atomising a lactose solution into a hot air stream. This process evaporates the solvent, yielding dry lactose particles in the 10–200 micron range with high surface area and porosity, making them excellent carriers for active ingredients.
Market Share by Region
North America held a significant revenue of the overall pharmaceutical grade lactose market share in the historical period, driven by the presence of established players like Pfizer, Johnson & Johnson, and Merck. The adoption of lactose-induced infant formula in the region has shown benefits such as improved digestion and prevention of gastrointestinal issues in infants, fostering increasing awareness among healthcare providers and parents.
In the Asia Pacific, government initiatives promoting the affordability of prescription drugs and encouraging foreign investments contribute to the market growth. The region’s distinctive landscape features numerous small-scale players with in-line manufacturing capabilities, contributing to anticipated significant growth over the forecast period.
Meanwhile, Europe witnesses a flourishing pharmaceutical industry due to a growing ageing population, resulting in heightened demand for medicines and healthcare services. The region boasts a robust foundation for research and development, with universities, research centres, and biotech companies driving innovation and new drug development. The European Union (EU) has implemented regulations and incentives to bolster the market growth and attract investments, further fuelling demand for the product, primarily used in tablets and capsules.
Competitive Landscape
Lactalis International, established in 1933 and based in Laval, France, is a dairy products provider. Some of its well-known dairy products are butter, cheese, cream, yoghurt, and baby formulas. The company’s leading international brands include Ambassador, Bridel, Galbani, Lactel, and Santal, among others.
MEGGLE GmbH & Co. KG, founded in 1887, is a milk and whey corporation, headquartered in Wasserburg am Inn, Germany. It primarily offers its products and services in the sectors of food, feed, and pharmaceutical. The company complies with GMP (good manufacturing practice) regulations, which are a necessity to supply inactive substances such as lactose to the pharmaceutical sector.
DFE Pharma GmbH & Co KG, a global leader in pharmaceutical excipient solutions, leverages over a century of experience and a workforce of 400+ individuals across 100+ countries. Headquartered in Goch, Germany, the company serves 5,000+ customers, providing high-quality functional excipients for the pharmaceutical, biopharmaceutical, and nutraceutical industries. DFE Pharma is dedicated to enhancing patients' lives by delivering reliable solutions in respiratory, oral solid dose, ophthalmic, and parenteral formulations.
Other pharmaceutical grade lactose market players include Fengchen Group Co.,Ltd, ALPAVIT, Kavya Pharma, and Surfachem Group Ltd., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Pharmaceutical Grade Lactose Market Analysis
8.1 Key Industry Highlights
8.2 Global Pharmaceutical Grade Lactose Historical Market (2018-2023)
8.3 Global Pharmaceutical Grade Lactose Market Forecast (2024-2032)
8.4 Global Pharmaceutical Grade Lactose Market by Type
8.4.1 Crystalline Monohydrate Lactose
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Inhalation Lactose
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Granulated Lactose
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Spray-dried Lactose
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.5 Others
8.5 Global Pharmaceutical Grade Lactose Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
9 North America Pharmaceutical Grade Lactose Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Pharmaceutical Grade Lactose Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Pharmaceutical Grade Lactose Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Pharmaceutical Grade Lactose Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Pharmaceutical Grade Lactose Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 DFE Pharma GmbH & Co KG
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Fengchen Group Co.,Ltd
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Lactalis International
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 ALPAVIT
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Kavya Pharma
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 MEGGLE GmbH & Co. KG
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Surfachem Group Ltd.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Pharmaceutical Grade Lactose Market: Key Industry Highlights, 2018 and 2032
2. Global Pharmaceutical Grade Lactose Historical Market: Breakup by Type (USD Billion), 2018-2023
3. Global Pharmaceutical Grade Lactose Market Forecast: Breakup by Type (USD Billion), 2024-2032
4. Global Pharmaceutical Grade Lactose Historical Market: Breakup by Region (USD Billion), 2018-2023
5. Global Pharmaceutical Grade Lactose Market Forecast: Breakup by Region (USD Billion), 2024-2032
6. North America Pharmaceutical Grade Lactose Historical Market: Breakup by Country (USD Billion), 2018-2023
7. North America Pharmaceutical Grade Lactose Market Forecast: Breakup by Country (USD Billion), 2024-2032
8. Europe Pharmaceutical Grade Lactose Historical Market: Breakup by Country (USD Billion), 2018-2023
9. Europe Pharmaceutical Grade Lactose Market Forecast: Breakup by Country (USD Billion), 2024-2032
10. Asia Pacific Pharmaceutical Grade Lactose Historical Market: Breakup by Country (USD Billion), 2018-2023
11. Asia Pacific Pharmaceutical Grade Lactose Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Latin America Pharmaceutical Grade Lactose Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Latin America Pharmaceutical Grade Lactose Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Middle East and Africa Pharmaceutical Grade Lactose Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Middle East and Africa Pharmaceutical Grade Lactose Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Global Pharmaceutical Grade Lactose Market Structure
Key Questions Answered in the Report
In 2023, the market reached an approximate value of USD 1.92 billion.
The market is projected to grow at a CAGR of 7.2% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach USD 3.63 billion by 2032.
The major market drivers include increasing spending in the healthcare/pharmaceutical industry and government initiatives facilitating affordable prescription drugs and creating an attractive environment for foreign investments.
Increasing demand for food, beverage, and infant formula industries and increasing adoption of 3D modelling in pharmaceutical industry are acting as key trends of the market.
North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa are the major regional markets for Pharmaceutical Grade Lactose.
The major types of Pharmaceutical Grade Lactose are crystalline monohydrate lactose, inhalation lactose, granulated lactose, and spray-dried lactose, among others.
The key players in the market are DFE Pharma GmbH & Co KG, Fengchen Group Co.,Ltd, Lactalis International, ALPAVIT, Kavya Pharma, MEGGLE GmbH & Co. KG, and Surfachem Group Ltd., among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER